plasmacytoid
dendrit
cell
pdc
constitut
bodi
princip
sourc
type
interferon
ifn
compar
abund
liver
among
variou
cytokin
implic
liver
ischemia
reperfus
ir
injuri
type
ifn
describ
recent
play
essenti
role
pathogenesi
moreov
type
ifn
shown
upregul
hepatocyt
express
ifn
regulatori
factor
key
transcript
factor
regul
apoptosi
induc
liver
damag
ir
aim
ascertain
capac
releas
liver
pdc
induc
liver
damag
hepat
upregul
ir
injuri
find
show
liver
pdc
matur
produc
respons
liver
ir
liver
pdc
isol
ir
induc
elev
level
product
hepatocyt
compar
liver
pdc
isol
shamoper
mice
notabl
hepat
express
reduc
significantli
neutral
vivo
neutral
protect
liver
ir
injuri
reduc
hepatocyt
apoptosi
associ
impair
express
proapoptot
molecul
fa
ligand
receptor
fa
death
receptor
regul
furthermor
pdcdeplet
mice
fail
upregul
hepat
display
less
liver
injuri
associ
reduc
level
hepat
tumor
necrosi
hepatocyt
apoptosi
ir
compar
control
conclus
data
support
hypothesi
deriv
liver
pdc
play
key
role
pathogenesi
liver
ir
injuri
enhanc
apoptosi
consequ
induct
hepatocyt
express
hepatocellular
injuri
caus
ischemiareperfus
ir
result
highli
complex
cascad
event
trigger
liver
expos
transient
hypoxia
reperfus
oxygen
blood
ir
injuri
unavoid
transplant
surgeri
advers
affect
patient
graft
outcom
recent
larg
studi
livingand
deceaseddonor
liver
transplant
patient
extend
cold
ischem
time
associ
elev
rate
earli
organ
failur
acut
cellular
reject
moreov
greater
suscept
extend
criteria
liver
graft
ischem
insult
ir
injuri
exacerb
donor
organ
shortag
problem
specif
treatment
avail
prevent
reduc
hepat
ir
injuri
current
manag
base
support
care
thu
extens
effort
warrant
better
understand
mechan
underli
liver
ir
injuri
type
interferon
ifn
multifunct
cytokin
activ
modul
immun
respons
type
ifn
bind
type
ifn
receptor
ifnar
activ
turn
phosphoryl
signal
transduc
activ
transcript
stat
promot
format
ifnstimul
gene
factor
isgf
complex
complex
bind
nuclear
ifnstimul
respons
element
isr
induc
transcript
ifnstimul
gene
isg
encod
factor
respons
antivir
antiprolif
immunoregulatori
respons
due
critic
role
innat
immun
type
ifn
use
therapeut
agent
viral
hepat
leukemia
renal
cell
carcinoma
multipl
sclerosi
hand
type
ifn
play
pathogen
role
autoimmun
diseas
psoriasi
system
lupu
erythematosu
sle
neutral
potenti
therapeut
approach
type
ifnrel
diseas
therapeut
effect
neutral
antibodi
ab
report
mous
model
hiv
enceph
septic
shock
recent
safeti
monoclon
antibodi
mab
confirm
chronic
psoriasi
phase
trial
type
ifn
regard
critic
factor
warm
cold
liver
ir
injuri
thu
mice
ifnar
ko
liver
protect
damag
suggest
neutral
might
therapeut
option
inhibit
liver
ir
injuri
transcript
factor
ifn
regulatori
factor
irf
induc
cytokin
type
ifn
tumor
necrosi
virus
retino
acid
regul
cell
prolifer
apoptosi
immun
respons
overexpress
promot
apoptosi
upregul
fa
ligand
hepatocyt
resist
apoptosi
known
play
key
role
liver
ir
injuri
sinc
high
mobil
group
box
releas
dyingdead
cell
upregul
hepatocyt
tolllik
receptor
tlr
ligat
promot
liver
injuri
furthermor
liver
exhibit
less
ir
injuri
correl
reduc
apoptosi
due
diminish
express
death
ligand
includ
fa
ligand
death
receptor
dr
although
type
ifn
produc
almost
cell
produc
mainli
plasmacytoid
dendrit
cell
pdc
produc
fibroblast
synoviocyt
stromal
cell
pdc
unconvent
subset
bone
marrowderiv
dc
produc
larg
amount
follow
ligat
although
rare
cell
pdc
recogn
import
player
protect
host
viral
infect
produc
contrast
pdc
sens
self
dna
produc
high
amount
drive
autoimmun
exacerb
sle
psoriasi
addit
pdc
produc
pro
antiinflammatori
cytokin
follow
tlr
ligat
thu
like
convent
dc
pdc
play
key
role
innat
adapt
immun
liver
convent
dc
implic
regul
liver
ir
injuri
date
data
avail
concern
role
pdc
hepat
ir
injuri
studi
hypothes
deriv
pdc
might
involv
pathogenesi
liver
ir
injuri
blockad
might
protect
liver
damag
inhibit
express
hepatocyt
consequ
reduc
apoptosi
data
show
pdc
activ
produc
liver
ir
promot
express
hepatocyt
vitro
vivo
neutral
significantli
reduc
liver
irinduc
damag
associ
reduct
proinflammatori
cytokin
death
receptor
fa
express
liver
moreov
deplet
pdc
vivo
reduc
hepat
protect
liver
ir
injuri
nonleth
model
segment
hepat
warm
ischemia
use
describ
mous
liver
expos
hour
ischemia
clamp
portal
triad
anim
euthan
hour
reperfus
neutral
experi
mab
clone
iv
abcam
inc
cambridg
inject
minut
ir
injuri
vivo
pdc
deplet
mice
inject
consecut
day
purefunct
grade
mab
ip
miltenyi
biotec
auburn
ca
pdc
isol
liver
mice
given
endogen
dc
poietin
fmslike
tyrosin
kinas
ligand
cho
cell
deriv
recombin
human
mouseday
ip
day
describ
thu
bulk
liver
dc
enrich
densiti
centrifug
use
nycodenz
sigma
st
loui
mo
pdc
purif
consist
cell
posit
select
dcenrich
fraction
use
immunomagnet
bead
paramagnet
ls
column
miltenyibiotec
liver
pdc
liver
nonparenchym
cell
npc
spleen
cell
treat
rat
antimous
mab
prevent
nonspecif
ab
bind
messeng
rna
mrna
express
quantifi
syber
green
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
abipr
sequenc
detect
system
pe
appli
biosystem
foster
citi
ca
primer
specif
hepatocyt
mous
isol
situ
collagenas
type
iv
sigma
perfus
techniqu
describ
hepatocyt
puriti
exceed
viabil
exceed
determin
standard
test
liver
pdc
sham
ir
injuri
mice
incub
without
stimul
accumul
supernat
pdc
respect
supernat
appli
hepatocyt
cultur
withwithout
mab
mous
pbl
interferon
sourc
piscataway
nj
use
posit
control
hr
cocultur
hepatocyt
harvest
rtpcr
hepatocyt
wt
cultur
without
uml
hr
hepatocyt
viabil
determin
mtt
assay
roch
appli
scienc
mannheim
germani
follow
manufactur
instruct
level
cultur
supernat
determin
use
commerci
elisa
kit
pbl
interferon
sourc
follow
manufactur
instruct
serum
alt
level
measur
use
opera
clinic
chemistri
system
bayer
co
tarrytown
ny
liver
tissu
sampl
fix
formalin
embed
paraffin
section
stain
h
e
tunel
termin
deoxynucleotidyl
transferas
tdt
mediat
dutp
nick
end
label
describ
data
express
mean
sd
signific
differ
mean
determin
nonparametr
mannwhitney
utest
p
valu
consid
signific
verifi
level
express
mous
liver
follow
warm
ir
realtim
rtpcr
perform
whole
liver
tissu
shown
fig
gene
transcript
markedli
significantli
upregul
approxim
hour
ir
compar
shamoper
control
mice
also
examin
phenotyp
function
liver
pdc
freshlyisol
liver
ir
shown
fig
liver
pdc
ir
injuri
mice
display
signific
increas
intens
express
mfi
cell
surfac
costimulatori
molecul
compar
pdc
shamoper
control
wherea
similar
level
major
histocompat
complex
mhc
class
ii
ia
b
express
group
moreov
freshlyisol
liver
pdc
ir
injuri
mice
secret
enhanc
quantiti
follow
hour
cultur
fig
induc
hepatocyt
stimul
proinflammatori
cytokin
type
ifn
therefor
next
examin
whether
releas
liver
pdc
liver
ir
injuri
might
upregul
express
cultur
hepatocyt
vitro
liver
pdc
isol
sham
oper
irinjur
mice
cultur
overnight
without
stimul
liver
pdc
accompani
supernat
transfer
mous
hepatocyt
cultur
hour
without
addit
neutral
mab
start
cocultur
product
hepatocyt
measur
rtpcr
shown
fig
liver
pdc
isol
shamoper
mice
significantli
greater
extent
irinjur
mice
upregul
product
mous
hepatocyt
notabl
neutral
significantli
reduc
abil
liver
pdc
irinjur
mice
induc
product
hepatocyt
confirm
involv
hepatocyt
apoptosi
viabil
hepatocyt
wt
ko
mice
presenc
examin
wherea
viabil
wt
hepatocyt
significantli
decreas
incub
ko
hepatocyt
affect
figur
shown
fig
upregul
mous
liver
ir
thought
involv
earli
pathogenesi
tissu
injuri
evalu
role
liver
ir
inject
mice
neutral
mab
isotyp
control
ig
immedi
liver
ir
injuri
evid
fig
serum
alt
level
hour
reperfus
significantli
lower
approx
mabtreat
mice
compar
control
group
fig
consist
reduct
alt
level
extent
tissu
necrosi
incid
tunel
apoptot
cell
hepatocyt
group
much
lower
untreat
ir
injuri
group
fig
time
gene
transcript
proinflammatori
cytokin
liver
tissu
reduc
significantli
ifn
neutral
mabinject
group
fig
potent
induc
promot
cell
apoptosi
fasrel
manner
ascertain
whether
protect
effect
neutral
vivo
associ
reduc
hepatocyt
apoptosi
due
downregul
express
liver
tissu
perform
realtim
rtpcr
death
ligand
fasl
death
receptor
fa
shown
fig
gene
transcript
level
liver
mice
much
lower
approx
isotypetr
control
mice
consist
mrna
level
fa
fasl
gene
transcript
regul
determin
extent
apoptosi
also
reduc
significantli
mous
liver
fig
data
suggest
protect
effect
neutral
liver
ir
injuri
due
reduc
apoptosi
result
less
induct
consequ
less
induct
death
receptor
death
ligand
regul
pdc
regard
main
sourc
bodi
investig
role
product
liver
ir
injuri
deplet
pdc
vivo
surgeri
use
mab
mice
inject
ip
three
consecut
day
purefunct
grade
ab
hour
last
inject
underw
ir
fig
show
profound
deplet
liver
pdc
siglech
achiev
mab
administr
induct
injur
liver
markedli
inhibit
reduct
pdc
deplet
fig
shown
fig
f
liver
pdcdeplet
mice
protect
ir
injuri
evidenc
reduct
serum
alt
c
tissu
damag
area
necrosi
number
tunel
cell
df
taken
togeth
data
suggest
liver
pdc
import
sourc
liver
ir
injuri
play
key
role
pathogenesi
ir
injuri
type
ifn
pleiotrop
cytokin
produc
dc
macrophag
immun
cell
fibroblast
virallyinfect
cell
contribut
viral
clearanc
diseas
pathogenesi
shown
recent
play
pathogen
role
warm
cold
liver
ir
injuri
thu
mice
ifnar
ko
liver
protect
injuri
specif
cytokin
eg
neutral
alreadi
prove
effect
approach
diseas
therapi
clinic
neutral
ab
alreadi
phase
clinic
trial
psoriasi
confirm
safeti
show
mark
reduct
murin
liver
warm
ir
injuri
either
select
deplet
pdc
neutral
possibl
underli
protect
mechan
impair
product
key
downstream
molecul
signal
liver
transcript
factor
induc
virus
doublestrand
rna
retino
acid
cytokin
includ
regul
cell
prolifer
apoptosi
immun
respons
show
studi
neutral
reduc
induct
hepatocyt
vitro
liver
ir
injuri
known
induc
apoptosi
increas
express
fasl
also
found
neutral
reduc
hepatocyt
apoptosi
liver
ir
injuri
consist
lower
express
death
ligand
fasl
death
receptor
fa
within
liver
result
suggest
neutral
attenu
induct
hepatocyt
consequ
fasfasl
express
result
reduc
apoptosi
follow
liver
ir
injuri
recent
irf
member
shown
contribut
pathogenesi
liver
warm
ir
injuri
structur
similar
compet
antagonist
klune
et
al
report
overexpress
protect
liver
ir
injuri
mechan
anoth
transcript
factor
involv
typei
ifn
proinflammatori
cytokin
product
tlr
stimul
interestingli
mice
exhibit
sever
warm
liver
injuri
due
greater
induct
enhanc
neutrophil
infiltr
type
ifn
immunostimulatori
capac
activ
immun
cell
includ
cell
natur
killer
nk
cell
dc
dc
produc
enhanc
level
proinflammatori
cytokin
promot
helper
cell
respons
studi
shown
neutral
decreas
key
proinflammatori
cytokin
liver
ir
injuri
find
consist
recent
observ
use
ifnar
ko
mice
although
identifi
sourc
proinflammatori
cytokin
data
suggest
involv
promot
proinflammatori
cytokin
product
liver
ir
injuri
pdc
compar
abund
liver
compar
secondari
lymphoid
tissu
regard
main
sourc
nonconvent
dc
predominantli
express
produc
high
amount
respons
ligat
although
tlr
receptor
recogn
singlestrand
rna
doublestrand
dna
pathogenassoci
molecular
pattern
viral
infect
pdc
sens
selfrna
selfdna
damageassoci
molecular
pattern
produc
studi
found
hepat
warm
ir
injuri
rapidli
upregul
gene
transcript
liver
hour
reperfus
find
consist
earlier
report
type
type
ii
ifn
receptor
ko
mice
protect
warm
liver
ir
damag
moreov
recent
use
clinicallyrelev
mous
model
extend
hepat
cold
preserv
follow
orthotrop
liver
transplant
olt
shen
et
al
shown
liver
graft
recipi
type
ifn
receptor
ko
defici
requir
amelior
ir
injuri
olt
notabl
present
studi
mice
profoundli
deplet
pdc
exhibit
less
tissu
damag
liver
ir
compar
control
mice
decreas
liver
injuri
pdcdeplet
mice
associ
signific
reduct
fig
hepat
tissu
interestingli
hour
reperfus
extent
hepat
messag
pdcdeplet
anim
lower
control
suggest
pdc
main
sourc
type
iifn
liver
compar
product
liver
pdc
kupffer
cell
much
abund
liver
pdc
play
role
regul
hepat
iri
howev
sinc
pdc
deplet
result
profound
reduct
hepat
express
may
conclud
liver
macrophag
major
sourc
sinc
anoth
type
ifn
may
produc
macrophag
liver
ir
injuri
share
downstream
signal
pathway
would
interest
futur
studi
address
vivo
function
ifn
model
also
show
follow
reperfus
liver
pdc
acquir
matur
phenotyp
secret
enhanc
amount
associ
higher
level
express
liver
liver
pdc
isol
warm
ir
activ
pdc
secret
contribut
enhanc
product
hepatocyt
taken
togeth
observ
suggest
ir
liver
pdc
may
activ
selfdna
produc
play
key
role
pathogenesi
ir
injuri
schemat
outlin
propos
mechan
suggest
find
shown
fig
convent
myeloid
dc
import
regul
innat
adapt
immun
implic
previous
regul
inflamm
tissu
injuri
liver
ir
inhibitori
enhanc
effect
report
recent
observ
suggest
local
liver
microenviron
play
import
role
determin
dc
function
ir
injuri
howev
previou
report
focus
role
pdc
hepat
ir
injuri
pdc
believ
exhibit
immunoregulatori
properti
due
poor
immunostimulatori
function
treg
induc
abil
product
deplet
cell
vivo
exacerb
viral
infect
asthma
transplant
reject
hand
present
studi
show
pdc
deplet
protect
liver
warm
ir
injuri
reveal
underli
patholog
role
cell
similarli
result
pdc
shown
play
patholog
role
experiment
allerg
encephalomyel
eae
mice
pdc
deplet
reduc
diseas
activ
type
ifn
deriv
pdc
import
inhibit
viral
replic
clearanc
type
ifn
also
pathogen
earli
phase
eae
liver
warm
ir
injuri
model
overal
observ
suggest
specif
role
type
ifn
experiment
model
may
determin
role
pdc
protect
pathogen
taken
togeth
novel
find
demonstr
secret
activ
pdc
involv
promot
hepat
ir
injuri
modul
express
proinflammatori
cytokin
importantli
regul
hepatocyt
apoptosi
data
provid
signific
new
insight
mechan
promot
liver
ir
injuri
via
pathway
support
therapeut
potenti
neutral
amelior
liver
ir
injuri
hepat
ir
injuri
stimul
phenotyp
matur
product
liver
interstiti
pdc
mice
underw
ir
injuri
describ
materi
method
hour
reperfus
liver
pdc
isol
immunomagnet
bead
sort
phenotyp
function
analys
perform
analysi
whole
liver
tissu
messag
realtim
rtpcr
b
cell
surfac
phenotyp
liver
pdc
int
ir
injuri
shamoper
control
mice
analyz
mab
stain
flow
cytometri
c
product
freshlyisol
liver
pdc
isol
hour
ir
injuri
measur
elisa
mice
per
group
p
ir
injuri
activ
liver
pdc
promot
product
hepatocyt
liver
pdc
isol
shamoper
ir
injuri
mice
incub
hour
accumul
cultur
supernat
thereaft
pdc
accompani
supernat
transfer
normal
mous
hepatocyt
cultur
hour
without
neutral
mab
ad
start
cultur
product
assess
rtpcr
mous
hepatocyt
cultur
without
use
posit
neg
control
respect
overal
analysi
independ
experi
p
b
hepatocyt
wt
ko
cultur
without
uml
hr
hepatocyt
viabil
determin
mtt
assay
p
vivo
neutral
reduc
liver
ir
injuri
associ
reduc
gene
express
mice
inject
iv
neutral
mab
mous
iv
isotyp
control
ig
minut
submit
ir
injuri
protect
effect
neutral
associ
downregul
gene
transcript
death
molecul
express
per
group
mice
inject
iv
neutral
mab
iv
isotyp
control
ig
minut
submit
ir
injuri
hour
reperfus
liver
tissu
harvest
b
death
ligand
fasl
death
receptor
fa
mrna
express
liver
tissu
evalu
realtim
rtpcr
p
vivo
pdc
deplet
protect
liver
ir
injuri
mice
inject
consecut
day
purefunct
grade
mab
ip
isotyp
control
ig
assess
deplet
effici
ab
freshlyisol
liver
nonparenchym
cell
stain
siglech
analyz
flow
cytometri
int
siglech
cell
pdc
gate
frequenc
calcul
data
repres
mice
per
group
bf
twentyfour
hour
final
mab
inject
vasculatur
suppli
left
median
lobe
liver
schemat
represent
propos
role
pdc
type
ifn
hepat
ir
vascular
occlus
involv
liver
hour
follow
hour
reperfus
induc
hepatocyt
necrosi
releas
damageassoci
molecular
pattern
damp
ligand
selfdna
selfdna
engag
hepat
pdc
turn
activ
releas
compar
larg
amount
type
ifn
thereaft
engag
receptor
ifnar
hepatocyt
induc
transcript
key
proinflammatori
factor
involv
pathogenesi
ir
injuri
abl
perpetu
liver
damag
releas
new
damp
block
type
ifn
use
neutral
mab
downregul
hepatocyt
concomit
reduct
hepatocyt
apoptosi
decreas
level
fa
proinflammatori
cytokin
result
reduc
liver
damag
elev
express
